ADME transcriptome in Hispanic versus White donor livers: Evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics

References

• Bowles J, Knight D, Smith C, Wilhelm D, Richman J, Mamiya S, Yashiro K, Chawengsaksophak K, Wilson MJ, Rossant J, Hamada H, Koopman P. Retinoid signaling determines germ cell fate in mice. Science 2006; 312: 596–600
   Google Scholar
• Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004; 40: 1387–1395
   PubMed Web of Science ®Google Scholar
• Bulera SJ, Eddy SM, Ferguson E, Jatkoe TA, Reindel JF, Bleavins MR, De La Iglesia F. RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 2001; 33: 1239–1258
   PubMed Web of Science ®Google Scholar
• Chen W, Koenigs LL, Thompson SJ, Peter RM, Rettie AE, Trager WF, Nelson SD. Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chemical Research in Toxicology 1998; 11: 295–301
   PubMed Web of Science ®Google Scholar
• Chen Y, Goldstein JA. PGC-1alpha regulates both the constitutive and drug-inducible expression of human CYP2C9. Federation American Society of Experimental Biology Abstracts 2006; 176: 5, (abstract)
   Google Scholar
• Chen Y, Kissling G, Negishi M, Goldstein JA. The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter. Journal of Pharmacology and Experimental Therapeutics 2005; 314: 1125–1133
   PubMed Web of Science ®Google Scholar
• Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proceedings of the National Academy of Sciences, USA 2004; 101: 7711–7715
   PubMed Web of Science ®Google Scholar
• Cheok MH, Yang W, Pui CH, Downing JR, Cheng C, Naeve CW, Relling MV, Evans WE. Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nature Genetics 2003; 34: 85–90
   PubMed Web of Science ®Google Scholar
• Danpure CJ. Molecular aetiology of primary hyperoxaluria type 1. Nephron and Experimental Nephrology 2004; 98: e39–e44
   Google Scholar
• Faucette SR, Sueyoshi T, Smith CM, Negishi M, LeCluyse EL, Wang H. Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. Journal of Pharmacology and Experimental Therapeutics, e publication 2 March 2006
   Google Scholar
• Faucette SR, Wang H, Hamilton GA, Jolley SL, Gilbert D, Lindley C, Yan B, Negishi M, LeCluyse EL. Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers. Drug Metabolism and Disposition 2004; 32: 348–358
   PubMed Web of Science ®Google Scholar
• Ferguson SS, Chen Y, LeCluyse EL, Negishi M, Goldstein JA. Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha. Molecular Pharmacology 2005; 68: 747–757
   PubMed Web of Science ®Google Scholar
• Fernandez-Canon JM, Baetscher MW, Finegold M, Burlingame T, Gibson KM, Grompe M. Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism. Molecular Cell Biology 2002; 22: 4943–4951
   PubMed Web of Science ®Google Scholar
• Furihata T, Hosokawa M, Masuda M, Satoh T, Chiba K. Hepatocyte nuclear factor-4alpha plays pivotal roles in the regulation of mouse carboxylesterase 2 gene transcription in mouse liver. Archives of Biochemistry and Biophysics 2006; 447: 107–117
   PubMed Web of Science ®Google Scholar
• Haas DW, Smeaton LM, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D’Aquila RT, De Gruttola V, et al. Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an adult AIDS clinical trials group study. Journal of Infectious Diseases 2005; 192: 1931–1942
   PubMed Web of Science ®Google Scholar
• Hanis CL, Hewett-Emmett D, Bertin TK, Schull WJ. Origins of U.S. Hispanics. Implications for diabetes. Diabetes Care 1991; 14: 618–627
   PubMed Web of Science ®Google Scholar
• Hartley DP, Dai X, He YD, Carlini EJ, Wang B, Huskey SW, Ulrich RG, Rushmore TH, Evers R, et al. Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression. Molecular Pharmacology 2004; 65: 1159–1171
   PubMed Web of Science ®Google Scholar
• Huang Y, Dai Z, Barbacioru C, Sadee W. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Research 2005; 65: 7446–7454
   PubMed Web of Science ®Google Scholar
• James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metabolism and Disposition 2003; 31: 1499–1506
   PubMed Web of Science ®Google Scholar
• Jover R, Bort R, Gomez-Lechon MJ, Castell JV. Cytochrome P450 regulation by hepatocyte nucler factor 4 in human hepatocytes: A study using adenovirus-mediated antisense targeting. Hepatology 2001; 33: 668–675
   PubMed Web of Science ®Google Scholar
• Kallwellis-Opara A, Zaho X, Zimmermann U, Unterman TG, Walther R, Schmoll D. Characterization of cis-elements mediating the stimulation of glucose-6-phosphate transporter promoter activity by glucocorticoids. Gene 2003; 320: 59–66
   PubMedGoogle Scholar
• Kishi S, Yang W, Boureau B, Morand S, Das S, Chen P, Cook EH, Rosner GL, Schuetz E, et al. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood 2005; 103: 67–72
   Google Scholar
• Lamba V, Lamba J, Yasuda K, Strom S, Davila J, Hancock M, Fackenthal JD, Rogan P, Ring B, et al. Hepatic CYP2B6 expression: Sex and ethnic differences and relationship to CYP2B6 genotype and CAR expression. Journal of Pharmacology and Experimental Therapeutics 2003; 307: 906–922
   PubMed Web of Science ®Google Scholar
• Lemonde HA, Custard EJ, Bouquet J, Duran M, Overmars H, Scambler PJ, Clayton PT. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. Gut. 2003; 52: 1494–1499
   PubMed Web of Science ®Google Scholar
• Li-Hawkins J, Lund EG, Bronson AD, Russell DW. Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. Journal of Biology and Chemistry 2000; 275: 16543–16549
   PubMed Web of Science ®Google Scholar
• Madan A, Graham RA, Carroll KM, Mudra DR, Burton LA, Krueger LA, Downey AD, Czerwinski M, Forster J, et al. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metabolism and Disposition 2003; 31: 421–431
   PubMed Web of Science ®Google Scholar
• Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, Kliewer SA. Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Molecular Pharmacology 2002; 62: 638–646
   PubMed Web of Science ®Google Scholar
• Martin HJ, Breyer-Pfaff U, Wsol V, Venz S, Block S, Maser E. Purification and characterization of akr1b10 from human liver: Role in carbonyl reduction of xenobiotics. Drug Metabolism and Disposition 2006; 34: 464–470
   PubMed Web of Science ®Google Scholar
• Maurel P. The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Advances in Drug Delivery Reviews 1996; 22: 105–132
   Web of Science ®Google Scholar
• Ornoy A. Neuroteratogens in man: An overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reproduction and Toxicology, e publication 16 April 2006
   Google Scholar
• Parkinson A, Mudra D, Johnson C, Dwyer A, Carroll K. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicology and Applied Pharmacology 2004; 199: 193–209
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Busson-Le Coniat M, Maurel P, Vilarem MJ. Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: Identification of a distal glucocorticoid element. Molecular Endocrinology 2003; 17: 42–55
   PubMed Web of Science ®Google Scholar
• Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: Functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochemistry Journal 2000; 351: 67–77
   PubMed Web of Science ®Google Scholar
• Pollock BH, DeBaun MR, Camitta BM, Shuster JJ, Ravindranath Y, Pullen DJ, Land VJ, Mahoney DH, Lauer SJ, et al. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Journal of Clinical Oncology 2000; 18: 813–823
   PubMed Web of Science ®Google Scholar
• Ramirez J, Komoroski BJ, Mirkov S, Graber AY, Fackenthal DL, Schuetz EG, Das S, Ratain MJ, Innocenti F, et al. Study of genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes. Pharmacogenetics and Genomics 2006; 16: 79–86
   PubMedGoogle Scholar
• Reijntjes S, Blentic A, Gale E, Maden M. The control of morphogen signalling: Regulation of the synthesis and catabolism of retinoic acid in the developing embryo. Developmental Biology 2005; 285: 224–237
   PubMed Web of Science ®Google Scholar
• Rosenfeld JM, Vargas R, Xie W, Evans RM. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor PXR. Molecular Endocrinology 2003; 17: 1268–1282
   PubMed Web of Science ®Google Scholar
• Rushmore TH, Kong A-NT. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Current Drug Metabolism 2002; 3: 481–490
   PubMed Web of Science ®Google Scholar
• Savas U, Hus MH, Johnson EF. Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Archives of Biochemistry and Biophysics 2003; 409: 212–220
   PubMed Web of Science ®Google Scholar
• Shiraki T, Sakai N, Kanaya E, Jingami H. Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor γ coactivator-1α. Journal of Biology and Chemistry 2003; 278: 11344–11350
   PubMed Web of Science ®Google Scholar
• Soars MG, Petullo DM, Eckstein JA, Kasper SC, Wrighton SA. An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes. Drug Metabolism and Disposition 2004; 32: 140–148
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Madan A, Carol KM, Parkinson A. Regulation of drug transporter gene expression by nuclear receptors. Drug Metabolism and Disposition 2003; 31: 523–527
   PubMed Web of Science ®Google Scholar
• Storey JD. Estimation methodology: A direct approach to false discovery rates. Journal of the Royal Statistical Society 2002; 64: 479–498
   Google Scholar
• Strom SC, Pisarov LA, Dorko K, Thompson MT, Schuetz JD, Schuetz EG. Use of human hepatocytes to study P450 gene induction. Methods Enzymol 1996; 272: 388–401
   PubMed Web of Science ®Google Scholar
• Tang H, Quertermous T, Rodriguez B, Kardia SLR, Zhu X, Brown A, Pankow JS, Province MA, Hunt SC, et al. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. American Journal of Human Genetics 2005; 76: 268–275
   PubMed Web of Science ®Google Scholar
• Thummel KE, Lee CA, Kunze KL, Nelson SD, Slattery JT. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochemistry and Pharmacology 1993; 45: 1563–1569
   PubMed Web of Science ®Google Scholar
• Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, et al. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nature Medicine 2003; 9: 220–224
   PubMed Web of Science ®Google Scholar
• Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, Afshari CA, Lehmann JM, Negishi M. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Molecular Pharmacology 2002; 61: 1–6
   PubMed Web of Science ®Google Scholar
• Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y. CATs and HATs: The SLC7 family of amino acid transporters. Pflugers Arch — European Journal of Physiology 2004; 447: 532–542
   PubMed Web of Science ®Google Scholar
• Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, Harris SC. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. Journal American Medical Association 2006; 296: 87–93
   PubMed Web of Science ®Google Scholar
• Wei P, Zhang J, Dowhan DH, Han Y, Moore DD. Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics Journal 2002; 2: 117–126
   PubMedGoogle Scholar
• Wei P, Zhang J, Egan-Hafley M, Liang S, Moore DD. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000; 407: 920–923
   PubMed Web of Science ®Google Scholar
• Wisely GB, Miller AB, Davis RG, Thornquest AD, Johnson R, Spitzer T, Sefler A, Shearer B, Moore JT, et al. Hepatocyte nucler factor 4 is a transcription factor that constitutively binds fatty acids. Structure (Cambridge) 2002; 10: 1225–1234
   PubMed Web of Science ®Google Scholar
• Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, Evans RM. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes and Development 2000; 14: 3014–3023
   PubMed Web of Science ®Google Scholar
• Xu RX, Lambert MH, Wisely BB, Warren EN, Weinert EE, Waitt GM, Williams JD, Collins JL, Moore LB, et al. A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Molecular Cell 2004; 16: 919–928
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Kawamoto T, Negishi M. The role of the nuclear receptor CAR as a coordinate regulator of hepatic gene expression in defense against chemical toxicity. Archives of Biochemistry and Biophysics 2003; 409: 207–211
   PubMed Web of Science ®Google Scholar
• Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, mahfouz R, Behm FG, Raimondi SC, Relling MV, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2005; 1: 133–143
   Google Scholar
• Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC–1. Nature 2001; 413: 131–138
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang W, Chua SS, Wei P, Moore DD. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 2002; 298(5592)422–424
   PubMed Web of Science ®Google Scholar